Invention Grant
- Patent Title: Chelator and use thereof
-
Application No.: US15937428Application Date: 2018-03-27
-
Publication No.: US10662261B2Publication Date: 2020-05-26
- Inventor: Mattias Algotsson , Lars C. Andersson , Eggert Brekkan , Lee Hedemyr , Jean-Luc Maloisel , Ronnie Palmgren
- Applicant: GE HEALTHCARE BIOPROCESS R&D AB
- Applicant Address: SE Uppsala
- Assignee: GE Healthcare BioProcess R&D AB
- Current Assignee: GE Healthcare BioProcess R&D AB
- Current Assignee Address: SE Uppsala
- Agency: Eversheds Sutherland (US) LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@7ed6d1e8
- Main IPC: C08B37/00
- IPC: C08B37/00 ; B01J20/289 ; B01J20/32 ; C07C237/10 ; C07C323/60 ; B01J20/281

Abstract:
The present invention relates to dimeric pentadentate chelators with exceptionally strong binding of metal ions, for detection, immobilization and purification of biomolecules. Dimeric chelators offer a cooperativity of binding of two adjacent immobilized metal ions simultaneously to a histidine-tagged biomolecule, which gives advantageous properties regarding strength of binding compared to a corresponding monomer chelator. In addition, a dimer increases the selectivity (ease of separation) against non-tagged biomolecules with low metal-ion affinity.
Public/Granted literature
- US20180223003A1 Novel Chelator and Use Thereof Public/Granted day:2018-08-09
Information query